Ticker Details
Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$949.7B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$3.54 | 0.96%
Avg Daily Range (30 D):	$13.62 | 1.43%
Avg Daily Range (90 D):	$13.51 | 1.37%

Institutional Daily Volume
Avg Daily Volume:	4.3M
Avg Daily Volume (30 D):	2.54M
Avg Daily Volume (90 D):	2.51M

Trade Size
Avg Trade Size (Sh.):	110
Avg Trade Size (Sh.) (30 D):	19
Avg Trade Size (Sh.) (90 D):	20

Institutional Trades
Total Institutional Trades:	87,855
Avg Institutional Trade:	$10.49M
Avg Institutional Trade (30 D):	$96.51M
Avg Institutional Trade (90 D):	$96.4M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	15

Market Closing Trades
Avg Closing Trade:	$94.86M
Avg Closing Trade (30 D):	$443.18M
Avg Closing Trade (90 D):	$458.51M
Avg Closing Volume:	415.78K

News

May 26, 2026 @ 6:06 AM Chamath Palihapitiya Said This To Eli Lilly's Gene... Source: Mohd Haider

May 25, 2026 @ 11:15 PM Eli Lilly Just Got a Huge Vote of Confidence From ... Source: Reuben Gregg Brewer

May 25, 2026 @ 9:05 AM Eli Lilly Just Made a Game-Changing Move in the Bi... Source: Adria Cimino

May 23, 2026 @ 8:31 PM Is Viking Therapeutics a Top Takeover Target? Source: Jeff Siegel

May 22, 2026 @ 9:15 PM The Most Important Healthcare Stock You're Not Wat... Source: Reuben Gregg Brewer

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$23	$7.4	$23
Diluted EPS	$22.95	$7.39	$22.95
Revenue	$65.18B	$19.29B	$65.18B
Gross Profit	$54.13B	$15.92B	$54.13B
Net Income / Loss	$20.64B	$6.64B	$20.64B
Operating Income / Loss	$25.73B	$8.27B	$25.73B
Cost of Revenue	$11.05B	$3.37B	$11.05B
Net Cash Flow	$4B	$-2523.5M	$4B
PE Ratio